The chief scientific officer at TScan Therapeutics discussed the company’s SafetyScan technology.
Gavin Macbeath, PhD
Advertisement
Chief scientific officer, TScan Therapeutics
Articles by Gavin Macbeath, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
2
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
3
Guess the Therapy Answer October 16, 2025
4
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
5
